688016 心脉医疗
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入1,014,7804.66%1,206,3271,187,204896,500684,631
减:营业总成本563,93527.21%663,428641,267507,452351,364
    其中:营业成本300,37926.43%325,577279,578222,513150,281
               财务费用(7,858)-34.79%(16,648)(8,414)(10,918)(11,408)
               资产减值损失(7,575)100.74%(4,690)(6,354)(2,232)(2,624)
公允价值变动收益------------
投资收益11,603-85.42%87,4119,1484,10315,014
    其中:对联营企业和合营企业的投资收益----931(3,769)(9,298)0
营业利润497,463-22.00%661,172573,854415,214362,776
利润总额497,543-21.80%652,194572,267413,895361,660
减:所得税费用74,478-16.37%159,44685,05061,84548,148
净利润423,065-22.68%492,748487,217352,051313,512
减:非控股权益(5,991)-2.76%(9,352)(5,215)(4,828)(2,344)
股东净利润429,056-22.46%502,100492,432356,878315,856

市场价值指针
每股收益 (元) *3.540-21.16%4.0706.8104.9604.390
每股派息 (元) *1.300-21.78%2.0123.0002.3002.100
每股净资产 (元) *32.1011.78%30.76246.46423.87820.760
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容